This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07617/identifier/chemspider/
n12http://bio2rdf.org/drugbank:
n9http://linked.opendata.cz/resource/drugbank/drug/DB07617/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n4http://linked.opendata.cz/resource/drugbank/drug/DB07617/identifier/pubchem-compound/
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://linked.opendata.cz/resource/drugbank/drug/DB07617/identifier/pubchem-substance/
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07617/identifier/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07617
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n11:DB07617 n12:DB07617
dcterms:title
N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE
adms:identifier
n4:11229234 n7:99444088 n8:DB07617 n9:D2G n14:9404282
n5:IUPAC-Name
n6:271B55C5-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B55CB-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B55CA-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B55C7-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B55C8-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B55C9-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B55C3-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B55C4-363D-11E5-9242-09173F13E4C5 n6:271B55C1-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B55C2-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B55D1-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B55D2-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B55CC-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B55CD-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B55CF-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B55CE-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B55D0-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B55D6-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B55D8-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B55D9-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B55D5-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B55D4-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B55D7-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B55C6-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B55D3-363D-11E5-9242-09173F13E4C5